Phase II study of chemotherapy with UFT/LV/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2618906
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: UFT 300mg/m2/day and LV 50mg/body/day is administered orally for 21 days every 28 days. Bevacizumab 5mg/kg is administered intravenous injection on day 1,15.
Primary outcome(s): Overall response rate
Study Design: Single arm Non-randomized
创建时间：
2010-04-15
